Hyderabad: Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration ...

In today's trade, shares of Maruti Suzuki, Dabur, Marico, Aurobindo Pharma, Angel One among others will be in focus due to ...

Aurobindo Pharma's subsidiary Apitoria Pharma has received 10 observations from the USFDA for its API manufacturing facility ...

Last week, brokerage firm UBS Securities also initiated a 'sell' call on Aurobindo Pharma, assigning it a price target of Rs ...

Aurobindo Pharma has also been granted competitive generic therapy designation for these Cephalexin Tablets, qualifying the ...

BSE, Angel One, IIFL Securities and 5 Paisa will be in focus because the Securities And Exchange Board Of India has increased ...

Here’s a quick look at stocks likely to be in focus in today's trade. Mankind Pharma has received the necessary regulatory ...

Aurobindo Pharma on Monday said the US health regulator has issued 10 observations after inspecting the API facility of its ...

The USFDA has issued 10 observations to Aurobindo Pharma's API manufacturing unit in Telangana after a September 2024 ...

Telangana: Aurobindo Pharma has announced that the United States Food and Drug Administration (US FDA) has issued ten ...

Zydus Lifesciences, Maruti Suzuki India, Dabur India, South Indian Bank, Allcargo Logistics, International Conveyors, NMDC, ...

Aurobindo Pharma receives USFDA approval for Cephalexin tablets, expected to launch in Q3FY25 with CGT designation.